Impaired Autophagy in APOE4 Astrocytes

Manuscript Number: 

15-1101R1

Author(s): 
Alina Bespalko, Dan Frenkel, David M. Holtzman, Tal Iram, Eliezer Masliah, Daniel M. Michaelson, Ronit Pinkas-Kramarski, Eran Schmukler, Shira Simonovitch

Disclosures

Alina Bespalko

  • Nothing to Disclose

Dan Frenkel

  • Nothing to Disclose

David M. Holtzman

  • Consulting Fees:
    Consulting: Eli Lilly, AbbVie, Ono pharma Scientific advisory boards: C2N Diagnostics, Genentech, Neurophage, Denali
    Equity:
    I am a co-founder of C2N Diagnostics, LLC and have equity in the company.
    Grants
    • Agency: 
      C2N Diagnostics
      Dates: 
      2014-2016
    • Agency: 
      Eli Lilly
      Dates: 
      2003-2018
    • Agency: 
      Denali pharma
      Dates: 
      2015-2016
    • Agency: 
      AbbVie
      Dates: 
      2015-2016

Tal Iram

  • Nothing to Disclose

Eliezer Masliah

  • Grants
    • Agency: 
      Neuropore Therapies
      Dates: 
      June 2015 to July 2016
    • Agency: 
      AC Immune
      Dates: 
      March 2015 to April 2016

Daniel M. Michaelson

  • Grants
    • Agency: 
      Neurimmune Ltd
      Dates: 
      2015 -2017

Ronit Pinkas-Kramarski

  • Nothing to Disclose

Eran Schmukler

  • Nothing to Disclose

Shira Simonovitch

  • Nothing to Disclose